WO2018056664A3 - 액상 플라즈마를 포함하는 비만 치료용 조성물 - Google Patents

액상 플라즈마를 포함하는 비만 치료용 조성물 Download PDF

Info

Publication number
WO2018056664A3
WO2018056664A3 PCT/KR2017/010234 KR2017010234W WO2018056664A3 WO 2018056664 A3 WO2018056664 A3 WO 2018056664A3 KR 2017010234 W KR2017010234 W KR 2017010234W WO 2018056664 A3 WO2018056664 A3 WO 2018056664A3
Authority
WO
WIPO (PCT)
Prior art keywords
liquid
phase plasma
composition
obesity treatment
treatment
Prior art date
Application number
PCT/KR2017/010234
Other languages
English (en)
French (fr)
Other versions
WO2018056664A2 (ko
Inventor
김철호
강성운
Original Assignee
아주대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020170102295A external-priority patent/KR101933920B1/ko
Application filed by 아주대학교산학협력단 filed Critical 아주대학교산학협력단
Priority to US16/335,925 priority Critical patent/US10537014B2/en
Publication of WO2018056664A2 publication Critical patent/WO2018056664A2/ko
Publication of WO2018056664A3 publication Critical patent/WO2018056664A3/ko

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H1/00—Generating plasma; Handling plasma
    • H05H1/24—Generating plasma
    • H05H1/247—Generating plasma using discharges in liquid media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/44—Applying ionised fluids

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 액상 플라즈마를 포함하는 비만 치료용 조성물에 관한 것이다. 보다 구체적으로, 본 발명은 지방세포 분화 또는 증식 억제용 액상 플라즈마의 제조 방법, 상기 방법에 의해 제조된 액상 플라즈마를 이용한 비만의 예방 또는 치료용 약제학적 조성물, 및 상기 액상 플라즈마를 이용한 비만의 예방 또는 치료 방법에 관한 것이다.
PCT/KR2017/010234 2016-09-22 2017-09-19 액상 플라즈마를 포함하는 비만 치료용 조성물 WO2018056664A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/335,925 US10537014B2 (en) 2016-09-22 2017-09-19 Composition for obesity treatment comprising liquid-phase plasma

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2016-0121357 2016-09-22
KR20160121357 2016-09-22
KR10-2017-0102295 2017-08-11
KR1020170102295A KR101933920B1 (ko) 2016-09-22 2017-08-11 액상 플라즈마를 이용한 비만의 예방 또는 치료 방법

Publications (2)

Publication Number Publication Date
WO2018056664A2 WO2018056664A2 (ko) 2018-03-29
WO2018056664A3 true WO2018056664A3 (ko) 2018-08-09

Family

ID=61690568

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/010234 WO2018056664A2 (ko) 2016-09-22 2017-09-19 액상 플라즈마를 포함하는 비만 치료용 조성물

Country Status (1)

Country Link
WO (1) WO2018056664A2 (ko)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080004452A (ko) * 2005-01-18 2008-01-09 엠에스큐 엘티디. 플라즈마 가스 방전으로 생물조직을 치료하는 시스템 및방법
KR101248668B1 (ko) * 2011-03-10 2013-03-28 부산대학교 산학협력단 저온 상압 플라즈마 노출을 이용한 세포의 생장 조절 방법
KR20130099522A (ko) * 2012-02-29 2013-09-06 아주대학교산학협력단 바이오-메디컬 응용을 위해 플라즈마를 이용하는 질환세포 및 병원성 미생물의 사멸 방법
KR20140084146A (ko) * 2011-10-13 2014-07-04 노파르티스 아게 신규 옥사진 유도체 및 질환의 치료에서의 그의 용도
KR101657063B1 (ko) * 2015-04-09 2016-09-13 아주대학교산학협력단 암 예방 또는 치료용 액상 플라즈마

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080004452A (ko) * 2005-01-18 2008-01-09 엠에스큐 엘티디. 플라즈마 가스 방전으로 생물조직을 치료하는 시스템 및방법
KR101248668B1 (ko) * 2011-03-10 2013-03-28 부산대학교 산학협력단 저온 상압 플라즈마 노출을 이용한 세포의 생장 조절 방법
KR20140084146A (ko) * 2011-10-13 2014-07-04 노파르티스 아게 신규 옥사진 유도체 및 질환의 치료에서의 그의 용도
KR20130099522A (ko) * 2012-02-29 2013-09-06 아주대학교산학협력단 바이오-메디컬 응용을 위해 플라즈마를 이용하는 질환세포 및 병원성 미생물의 사멸 방법
KR101657063B1 (ko) * 2015-04-09 2016-09-13 아주대학교산학협력단 암 예방 또는 치료용 액상 플라즈마

Also Published As

Publication number Publication date
WO2018056664A2 (ko) 2018-03-29

Similar Documents

Publication Publication Date Title
EP3848370A3 (en) Tyk2 inhibitors and uses thereof
EP4327809A3 (en) Tyk2 inhibitors and uses thereof
EP3356595A4 (en) METHODS OF PRODUCING NANOCELLULOSE, AND NANOCELLULOSE COMPOSITIONS PRODUCED THEREFROM
MX2017012009A (es) Derivado de un anillo condensado y metodo de preparacion, compuesto intermedio, composicion farmaceutica y uso del mismo.
EP3294761A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF UROPATHOGEN E. COLI
EP3380471B8 (en) Tetrahydro-8h-pyrido[1,2-a]pyrazine-8-ones as comt inhibitors for the treatment of neurodegenerative disorders
WO2015191945A3 (en) Solid state forms of sofosbuvir
IL254391A0 (en) kv1.3 suppressor compounds, methods for their production and uses thereof
WO2017066261A3 (en) Oxidation and sublimation prevention for thermoelectric devices
EP4339192A3 (en) Compounds and compositions for the treatment of cancer
EP3220943A4 (en) Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
EP3572095A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HTLV-1 ASSOCIATED MYELOPATHIA
WO2016167944A3 (en) Compositions and methods for treating autism
ZA201805407B (en) Composition for the prevention or treatment of neurodegenerative diseases.
ZA201806806B (en) Method for the treatment or prevention of osteoarthritis.
IL275573A (en) Methods and preparations for the treatment of hypercytokinemia and severe influenza or for their prevention
EP4286005A3 (en) Cancer treatment
EP3556381A4 (en) MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND ITS USES
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
WO2016080796A3 (ko) 세스퀴테르펜 화합물을 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물 및 이의 용도
EP3185883A4 (en) Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
WO2017120527A3 (en) Therapeutic compositions and methods for treating hepatitis b
WO2017019951A3 (en) Compositions amd methods of treating acne and photoaging
WO2016109002A3 (en) Methods and compositions for the treatment of radiation-related disorders
EP3461486C0 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DEMENTIA AND FOR IMPROVING COGNITIVE FUNCTION CONTAINING ACANTHOSIDE B FROM A SOURCE EXTRACT

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17853378

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17853378

Country of ref document: EP

Kind code of ref document: A2